The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

LGP by the numbers
More From The Market Online
The Market Online Video

HotCopper Highlights, Week 49: ASX Ltd shoots itself in foot again, NextDC-OpenAI & more

Good afternoon and welcome to HotCopper Highlights, I’m Jon Davidson, in this segment we go through the most viewed and most discussed stocks
ASX concept

ASX announcement outage issue all sorted on Tuesday, but reputational damages remain

More pain for the listed equities in ASX Ltd (ASX:ASX), the share market operator itself, after a Monday morning
A HotCopper-branded graphic image which reads "Insider Trades: Key director trades to watch" in front of an ASX-themed image which has been faded.

Pantoro, WEB, Energy One: All the biggest ASX director trades from the last week

Welcome to HotCopper’s Director Trades column, where we take a look at all the most interesting director transactions from across the past week and break